Patents Assigned to STARGET PHARMA LTD.
  • Publication number: 20240165282
    Abstract: Embodiments of the invention relate to somatostatin receptor selective peptides to somatostatin receptor 3, methods for synthesizing the somatostatin analogs and pharmaceutical, and radiopharmaceutical compositions comprising somatostatin receptor 3 analogs, and methods of using such compositions are disclosed for treatment and for diagnosis.
    Type: Application
    Filed: March 3, 2022
    Publication date: May 23, 2024
    Applicant: STARGET PHARMA LTD.
    Inventors: Michel AFARGAN, Eliav BLUM, Yoseph SALITRA